Summit Therapeutics PLC (SMMT)

NASDAQ
1.630
-0.140(-7.91%)
After Hours
1.630
0.000(0.00%)
- Real-time Data
  • Volume:
    2,212,181
  • Day's Range:
    1.590 - 1.820
  • 52 wk Range:
    0.660 - 5.780

SMMT Overview

Prev. Close
1.77
Day's Range
1.59-1.82
Revenue
705K
Open
1.75
52 wk Range
0.66-5.78
EPS
-0.407
Volume
2,212,181
Market Cap
1.23B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,917,815
P/E Ratio
-4.07
Beta
-1.01
1-Year Change
-34.93%
Shares Outstanding
697,685,365
Next Earnings Date
May 15, 2023
What is your sentiment on Summit Therapeutics PLC?
or
Market is currently closed. Voting is open during market hours.

Summit Therapeutics PLC Company Profile

Summit Therapeutics PLC Company Profile

Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily oncology therapies in the United States, and the United Kingdom. The company’s product pipeline includes SMT-738, a novel class of precision antibiotics for treatment which is in preclinical stage for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. for research and develop Ivonescimab (AK112) and SMT112, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis. The company was founded in 2003 and is headquartered in Cambridge, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellStrong SellStrong SellStrong Sell
Technical IndicatorsSellStrong SellStrong SellSellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • This seems promising
    0
    • ∆ SYMBOLS that can not be SHORT Must not BUY and DELETE Forever. 🤗🤩👍👹💣∆
      0
      • Summit on the way up!
        0
        • what happens here ? anybody ? somebody knows ? what is this rocket ?
          0
          • interesting progress they are making in the field of vaccines.. keep the good job.
            0
            • this will be a very interesting to look at when the market opens.
              0